McKESSON CORPORATION Interest Expense
McKESSON CORPORATION (MCK) reported Interest Expense of $67.00 million for the 3-month period ending 2024-12-31, per its 10-Q filed 2025-02-06.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2025-02-06
- McKESSON CORPORATION interest expense for the quarter ending 2024-12-31 was $67.00M, a 4.69% increase year-over-year.
- McKESSON CORPORATION interest expense for the quarter ending 2024-09-30 was $78.00M, a 27.87% increase year-over-year.
- McKESSON CORPORATION interest expense for the quarter ending 2024-06-30 was $75.00M, a 59.57% increase year-over-year.
- McKESSON CORPORATION interest expense for the quarter ending 2024-03-31 was $80.00M, a 1.27% increase year-over-year.
- McKESSON CORPORATION interest expense for fiscal 2024 was $252.00M, a 1.61% increase from fiscal 2023.
- McKESSON CORPORATION interest expense for fiscal 2023 was $248.00M, a 39.33% increase from fiscal 2022.
- McKESSON CORPORATION interest expense for fiscal 2022 was $178.00M, a 17.97% decline from fiscal 2021.
- McKESSON CORPORATION interest expense for fiscal 2021 was $217.00M, a 12.85% decline from fiscal 2020.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-12-31 | $67.00M 10-Q · filed 2025-02-06 | $145.00M derived: sum of 2 quarters · filed 2025-02-06 | $220.00M 10-Q · filed 2025-02-06 | $300.00M derived: sum of 4 quarters · filed 2025-02-06 |
| 2024-09-30 | $78.00M 10-Q · filed 2024-11-07 | $153.00M 10-Q · filed 2024-11-07 | $233.00M derived: sum of 3 quarters · filed 2024-11-07 | $297.00M derived: sum of 4 quarters · filed 2025-02-06 |
| 2024-06-30 | $75.00M 10-Q · filed 2024-08-07 | $155.00M derived: sum of 2 quarters · filed 2024-08-07 | $219.00M derived: sum of 3 quarters · filed 2025-02-06 | $280.00M derived: sum of 4 quarters · filed 2025-02-06 |
| 2024-03-31 | $80.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-08 | $144.00M derived: sum of 2 quarters · filed 2025-02-06 | $205.00M derived: sum of 3 quarters · filed 2025-02-06 | $252.00M 10-K · filed 2024-05-08 |
| 2023-12-31 | $64.00M 10-Q · filed 2025-02-06 | $125.00M derived: sum of 2 quarters · filed 2025-02-06 | $172.00M 10-Q · filed 2025-02-06 | $251.00M derived: sum of 4 quarters · filed 2025-02-06 |
| 2023-09-30 | $61.00M 10-Q · filed 2024-11-07 | $108.00M 10-Q · filed 2024-11-07 | $187.00M derived: sum of 3 quarters · filed 2024-11-07 | $256.00M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $47.00M 10-Q · filed 2024-08-07 | $126.00M derived: sum of 2 quarters · filed 2024-08-07 | $195.00M derived: sum of 3 quarters · filed 2024-08-07 | $250.00M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | $79.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-08 | $148.00M derived: sum of 2 quarters · filed 2024-05-08 | $203.00M derived: sum of 3 quarters · filed 2024-05-08 | $248.00M 10-K · filed 2024-05-08 |
| 2022-12-31 | $69.00M 10-Q · filed 2024-02-08 | $124.00M derived: sum of 2 quarters · filed 2024-02-08 | $169.00M 10-Q · filed 2024-02-08 | $212.00M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-09-30 | $55.00M 10-Q · filed 2023-11-02 | $100.00M 10-Q · filed 2023-11-02 | $143.00M derived: sum of 3 quarters · filed 2024-05-08 | $184.00M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-06-30 | $45.00M 10-Q · filed 2023-08-02 | $88.00M derived: sum of 2 quarters · filed 2024-05-08 | $129.00M derived: sum of 3 quarters · filed 2024-05-08 | $174.00M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-03-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-08 | $84.00M derived: sum of 2 quarters · filed 2024-05-08 | $129.00M derived: sum of 3 quarters · filed 2024-05-08 | $178.00M 10-K · filed 2024-05-08 |
| 2021-12-31 | $41.00M 10-Q · filed 2023-02-02 | $86.00M derived: sum of 2 quarters · filed 2023-02-02 | $135.00M 10-Q · filed 2023-02-02 | $187.00M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-09-30 | $45.00M 10-Q · filed 2022-11-02 | $94.00M 10-Q · filed 2022-11-02 | $146.00M derived: sum of 3 quarters · filed 2023-05-09 | $201.00M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-06-30 | $49.00M 10-Q · filed 2022-08-04 | $101.00M derived: sum of 2 quarters · filed 2023-05-09 | $156.00M derived: sum of 3 quarters · filed 2023-05-09 | $206.00M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-03-31 | $52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-09 | $107.00M derived: sum of 2 quarters · filed 2023-05-09 | $157.00M derived: sum of 3 quarters · filed 2023-05-09 | $217.00M 10-K · filed 2023-05-09 |
| 2020-12-31 | $55.00M 10-Q · filed 2022-02-03 | $105.00M derived: sum of 2 quarters · filed 2022-02-03 | $165.00M 10-Q · filed 2022-02-03 | |
| 2020-09-30 | $50.00M 10-Q · filed 2021-11-02 | $110.00M 10-Q · filed 2021-11-02 | ||
| 2020-03-31 | $249.00M 10-K · filed 2022-05-09 | |||
| 2019-03-31 | $264.00M 10-K · filed 2021-05-12 | |||
| 2018-03-31 | $283.00M 10-K · filed 2020-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cencora, Inc. (COR) | United States | $59.130B | 20.57 |
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |